| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2007, p. 338-342, Vol. 51, No. 1
0066-4804/07/$08.00+0 doi:10.1128/AAC.00498-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Achillion Pharmaceuticals, New Haven, Connecticut 06511
Received 21 April 2006/ Returned for modification 1 June 2006/ Accepted 25 October 2006
Replication complexes of hepatitis C virus synthesized two major species of viral RNA in vitro, double stranded and single stranded. NS5B nonnucleoside inhibitors inhibited dose dependently the synthesis of single-stranded RNA but not double-stranded RNA. Moreover, replication complexes carrying a mutation resistant to a nonnucleoside inhibitor lost their susceptibilities to the inhibitor.
Published ahead of print on 6 November 2006.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |